Search For "biologics"
Biocon Biologics gets Rs 555 crore capital injection from ADQ
Updated : 5 years, 2 months ago IST
Bengaluru (Karnataka) [India], Jan 7 (ANI): Abu Dhabi-based ADQ will invest Rs 555 crore for 1.8 per cent minority stake in Biocon Biologics, valuing it at a post money valuation of 4.17 billion dollars (about Rs 30,482 crore).
Read More
US FDA probing 'about five' allergic reactions to Pfizer COVID-19 vaccine
Updated : 5 years, 2 months ago IST
Washington [US], December 19 (ANI/Sputnik): The US Food and Drug Administration (FDA) is probing roughly five instances of individuals having allergic reactions to Pfizer and BioNTech's vaccine against COVID-19, Peter Marks, the director of the FDA's Center for Biologics Evaluation and Resea
Read More
First Russian volunteers inoculated with China's COVID-19 vaccine
Updated : 5 years, 5 months ago IST
Moscow [Russia], September 21 (ANI/Sputnik): Russian pharmaceutical company Petrovax launched phase 3 clinical trials of the Chinese Covid-19 vaccine candidate, CanSino Biologics Ad5-nCoV, on the first group of Russian volunteers in Moscow, the company said on Monday.
Read More
New insulin glargine injection launched in US for diabetes patients
Updated : 5 years, 6 months ago IST
Bengaluru (Karnataka) [India], Aug 31 (ANI): Biocon Biologics and Mylan on Monday announced the US launch of Semglee™ (insulin glargine injection) in vial and pre-filled pen presentations, approved to help control high blood sugar in adult and paediatric patients with type 1 diabetes a
Read More
Hyderabad-based Biological E inks agreement with Janssen Pharmaceutica for
Updated : 5 years, 7 months ago IST
Hyderabad (Telangana) [India], August 14 (ANI): Hyderabad-based pharmaceuticals and biologics firm Biological E. Limited (BE) on Thursday entered into an agreement with Janssen Pharmaceutica NV, part of pharma major Johnson & Johnson, for the creation and enhancement of manufacturing cap
Read More
Tata Capital to pick minority stake in Biocon Biologics for Rs 225 cr
Updated : 5 years, 7 months ago IST
Bengaluru (Karnataka) [India], July 31 (ANI): Private equity major Tata Capital Growth Fund will pick up 0.85 per cent stake in the biologics arm of biopharmaceutical major Biocon for Rs 225 crore.
Read More
Biocon Biologics and Voluntis join hands for global collaboration on dig
Updated : 5 years, 7 months ago IST
Bengaluru (Karnataka) [India], July 21 (ANI): Biocon Biologics India Limited, a fully integrated 'pure-play' biosimilars company, a subsidiary of Biocon Ltd. on Tuesday announced a global collaboration agreement between Biocon Biologics' subsidiary Biocon Sdn. Bhd., Malaysia and Voluntis to
Read More
Biocon Biologics appoints M B Chinappa as new CFO
Updated : 6 years, 2 months ago IST
Bengaluru (Karnataka) [India], Jan 7 (ANI): Biocon Ltd has appointed M B Chinappa as the Chief Financial Officer of its subsidiary Biocon Biologics India Ltd.
Read More
True North to invest Rs 536 crore in Biocon Biologics for 2.4 pc stake
Updated : 6 years, 2 months ago IST
Bengaluru (Karnataka) [India], Jan 6 (ANI): Biopharmaceuticals major Biocon said on Monday the board of its subsidiary Biocon Biologics has approved a primary equity investment by True North which will invest Rs 536.25 crore to pick 2.44 per cent minority stake in the biosimilars business.
Read More
Biocon's Biologics drug products facility gets nod from US FDA
Updated : 6 years, 4 months ago IST
Bengaluru (Karnataka) [India], Nov 5 (ANI): Biopharmaceuticals major Biocon Ltd said on Tuesday it has received an establishment inspection report from the US Food and Drug Administration (FDA) for its biologics drug product facility here, reaffirming its global scale manufacturing capabilit
Read More
Biocon Biologics expands R&D footprint by acquiring assets of Pfizer Healt
Updated : 6 years, 5 months ago IST
Bengaluru (Karnataka) [India], Sep 24 (ANI): Biopharmaceuticals major Biocon Ltd said on Tuesday that its subsidiary has acquired research and development capital assets from Pfizer Healthcare India Ltd.
Read More
Syngene International, Zumutor Biologics announce health-linked partnershi
Updated : 7 years, 9 months ago IST
Bengaluru [India], May 31 (ANI): Syngene International, a research company, has entered into a non-exclusive partnering agreement with Zumutor Biologics, an emerging immuno-oncology company, to access Zumutor's proprietary naïve human phage/yeast display library.
Read More